Status:
COMPLETED
Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
E Coli Infections
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to review patients with E. coli infections at UPMC from September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the community rather than in h...
Detailed Description
De-identified data will be obtained by the honest broker for the requested time period. In addtion, the honest broker will work with the microbiology laboratory to collect the isolates associated with...
Eligibility Criteria
Inclusion
- patients with E. coli infections at UPMC
Exclusion
- not meeting entry criteria
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00877708
Start Date
March 1 2009
End Date
December 1 2017
Last Update
June 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC
Pittsburgh, Pennsylvania, United States, 15213